DEBx Medical

24/08/2026

Blasting Biofilm in 60 Seconds Flat!

That is the title of vascular nurse practitioner Nicola Morley's presentation who is taking the stage at Wounds Australia 2026 to present her latest research on treating hard-to-heal wounds using the Topical Desiccating Agent: DEBRICHEM®.

𝗧𝗶𝘁𝗹𝗲: 𝘛𝘰𝘱𝘪𝘤𝘢𝘭 𝘋𝘦𝘴𝘪𝘤𝘤𝘢𝘵𝘪𝘯𝘨 𝘈𝘨𝘦𝘯𝘵: 𝘉𝘭𝘢𝘴𝘵𝘴 𝘣𝘪𝘰𝘧𝘪𝘭𝘮 𝘢𝘯𝘥 𝘴𝘭𝘰𝘶𝘨𝘩 𝘪𝘯 60 𝘴𝘦𝘤𝘰𝘯𝘥𝘴' 𝘧𝘭𝘢𝘵
Wednesday, Aug 26, 2026 | 11:30 – 13:00 (Presentation at 11:45)
Poster Gallery, Exhibition Hall

𝗞𝗲𝘆 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀:
➡️ All treated wounds achieved visible reduction in slimy, sloughy coating within a 2-week period
➡️ Rapid transition to granulation and contraction, compared to the prior 3 months
➡️ Visibly less Pseudomonal contamination across cases
➡️ Favourable improvements noted in all cases treated with DEBRICHEM®

Make sure to drop by the Poster Gallery during the Wednesday lunch session to hear Nicola present her findings and discuss these clinical outcomes!

If you have any questions, feel free to drop an email at [email protected] or connect with Catherine Murray-Leslie ahead of the event: https://tinyurl.com/mwx2pyj3

21/08/2026

𝗪𝗲𝗯𝗶𝗻𝗮𝗿 𝗔𝗹𝗲𝗿𝘁 [𝗜𝗡 𝗦𝗣𝗔𝗡𝗜𝗦𝗛]: Join Dra. Claudia Caicedo for an educational webinar on 𝘊𝘩𝘦𝘮𝘪𝘤𝘢𝘭 𝘋𝘦𝘣𝘳𝘪𝘥𝘦𝘮𝘦𝘯𝘵 𝘪𝘯 𝘵𝘩𝘦 𝘋𝘪𝘢𝘣𝘦𝘵𝘪𝘤 𝘍𝘰𝘰𝘵: 𝘈𝘯 𝘐𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘷𝘦 𝘚𝘵𝘳𝘢𝘵𝘦𝘨𝘺 𝘧𝘰𝘳 𝘉𝘪𝘰𝘧𝘪𝘭𝘮 𝘔𝘢𝘯𝘢𝘨𝘦𝘮𝘦𝘯𝘵

➡️ 𝗗𝗮𝘁𝗲 & 𝗧𝗶𝗺𝗲: Wednesday, August 26th, 2026 | 19:00 (CST – Mexico City)
➡️ 𝗗𝘂𝗿𝗮𝘁𝗶𝗼𝗻: ~60 minutes
➡️ 𝗟𝗮𝗻𝗴𝘂𝗮𝗴𝗲: Spanish (with live Q&A)

Dra. Claudia Caicedo is an Orthopedic Surgeon and Foot & Ankle Specialist at Hospital de San José - Bogotá, Colombia). She is also a Fellow at AO University Hospital Carl Gustav Carus in Dresden, Germany and a Full Member of the Colombian Society of Orthopedic Surgery and Traumatology (Sociedad Colombiana de Ortopedia y Traumatología (SCCOT).

𝗪𝗵𝗮𝘁'𝗹𝗹 𝘁𝗵𝗲 𝘀𝗲𝘀𝘀𝗶𝗼𝗻 𝗰𝗼𝘃𝗲𝗿:
🔹The impact of biofilm on diabetic foot wound healing
🔹The role of DEBRIX® in advanced biofilm management
🔹Clinical evidence, outcomes, and patient selection
🔹Best practices and practical insights from clinical cases.

The webinar is organized by Amcichac Mexico (Mexican Association for Comprehensive Wound Care and Healing), one of Mexico’s leading scientific organizations dedicated to advancing wound care education and promoting best clinical practices, in collaboration with Biotechlives Skin, our trusted Mexican partner.

🔗 𝗦𝗮𝘃𝗲 𝘆𝗼𝘂𝗿 𝘀𝗽𝗼𝘁: https://lnkd.in/eePCbpbj

----------

👉 Learn more. Access all DEBRIX® publications: https://lnkd.in/ex9vxCNd

👉 EXPERIENCE DEBRIX® FIRSTHAND. Schedule a FREE Demonstration: https://lnkd.in/ec8ytBwM

12/08/2026

DEBRIX® will be showcased at the 52.ª Semana Quirúrgica Nacional in Cartagena, Colombia (52nd National Surgical Congress) organised by the Asociación Colombiana de Cirugía

Innovacure - Innovando en la curación de heridas, our trusted partner in Colombia will welcome clinicians to Booth #5 at the event to learn about DEBRIX® and its role in advanced wound bed preparation.

𝗗𝗮𝘁𝗲𝘀: 18-21 August 2026
𝗟𝗼𝗰𝗮𝘁𝗶𝗼𝗻: Hotel Las Américas | Convention Center, Cartagena, Colombia

Visit Booth #𝟱 to
➡️ Understand the mechanics, role, and clinical value of TDA DEBRIX® in wound bed preparation.
➡️ Discover how swift biofilm removal in 60 seconds clears the path for progression toward healthy granulation.
➡️ Explore where DEBRIX® may fit within a comprehensive wound care pathway.

💬 Connect with Innovacure representatives and product specialists for dedicated Q&A sessions.
📄 Access educational resources, scientific papers, and technical materials to broaden your knowledge base.

If you are attending the congress in Cartagena, make sure to stop by Booth #5. The Innovacure team looks forward to connecting with the Colombian surgical community and demonstrating the clinical impact of DEBRIX®!

If you have any questions about DEBRIX®, you can also reach out to us at [email protected]

05/08/2026

High-resolution Scanning electron microscopy (SEM) visually captures biofilm collapse within seconds of DEBRICHEM® treatment.

A peer-reviewed study published in the 𝘐𝘯𝘵𝘦𝘳𝘯𝘢𝘵𝘪𝘰𝘯𝘢𝘭 𝘑𝘰𝘶𝘳𝘯𝘢𝘭 𝘰𝘧 𝘔𝘰𝘭𝘦𝘤𝘶𝘭𝘢𝘳 𝘚𝘤𝘪𝘦𝘯𝘤𝘦𝘴, researchers evaluated DEBRICHEM® across three biofilm models simulating chronic wound conditions and collected images of results at microscopic level. Each model was tested in triplets for reliability.

The findings were unmistakable. SEM imaging consistently revealed rapid biofilm eradication:

➡️ 𝗠𝗕𝗘𝗖 𝗠𝗼𝗱𝗲𝗹 (𝗻𝗲𝗰𝗿𝗼𝘁𝗶𝗰 𝘄𝗼𝘂𝗻𝗱 𝘀𝘂𝗿𝗳𝗮𝗰𝗲𝘀): Dense microbial clusters collapsed, leaving only lysed, disrupted cells.
➡️ 𝗖𝗗𝗖 𝗕𝗶𝗼𝗳𝗶𝗹𝗺 𝗥𝗲𝗮𝗰𝘁𝗼𝗿 (𝗲𝘅𝘂𝗱𝗮𝘁𝗶𝘃𝗲 𝘄𝗼𝘂𝗻𝗱𝘀): Thick aggregates and protective matrix structures disappeared, with no intact clusters remaining.
➡️ 𝗦𝗲𝗺𝗶-𝗦𝗼𝗹𝗶𝗱 𝗪𝗼𝘂𝗻𝗱 𝗠𝗼𝗱𝗲𝗹 (𝗶𝗻𝗳𝗲𝗰𝘁𝗲𝗱 𝘀𝗼𝗳𝘁 𝘁𝗶𝘀𝘀𝘂𝗲): Biofilms embedded in agar-based wound simulation medium were not suitable for SEM preparation, but quantitative analysis confirmed complete eradication consistent with the other models.

📷 SEM images below show clear architectural breakdown of biofilms after treatment. This microscopic disruption translates into macroscopic outcomes: reset of the wound environment and reopening of the pathways to healing.

👉 𝗘𝘅𝗽𝗹𝗼𝗿𝗲 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝘀𝘁𝘂𝗱𝘆 𝗵𝗲𝗿𝗲: Single-Application Biofilm Removal: Compelling Evidence from Three Biofilm Models & Electron Microscopy: https://lnkd.in/eZjZ7aQw

👉 𝗔𝗰𝗰𝗲𝘀𝘀 𝘁𝗵𝗲 𝗽𝘂𝗯𝗹𝗶𝘀𝗵𝗲𝗱 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗮𝗿𝘁𝗶𝗰𝗹𝗲 𝗵𝗲𝗿𝗲: https://lnkd.in/ePJSqNPU

𝗥𝗲𝗰𝗼𝗺𝗺𝗲𝗻𝗱𝗲𝗱 𝗔𝗿𝘁𝗶𝗰𝗹𝗲𝘀
✅ Broad-Spectrum Success of DEBRICHEM®: https://lnkd.in/e-Nj6E7k
✅ Powerful Anti-Biofilm Agent Restarts Wound Healing in 60 Seconds: https://lnkd.in/dk_rKDw4
✅ Accelerating Granulation in Wound Healing: https://lnkd.in/dFki_8kc
✅ Role of T.I.M.E.R.S. in Standard of Wound Care: https://lnkd.in/d7NBfk6g
✅ Different Methods of Debridement: An Overview: https://lnkd.in/dDsF-4FR
✅ Combining an Acidic Compound and NPWT: https://lnkd.in/dYAMdN3F
✅ Stabilization of an End-Stage Wound in a Vascular Compromised Amputated Case: https://lnkd.in/dyRgTy8z

24/07/2026

Join Miguel Ángel Mellado Sanz for an educational webinar on wound bed preparation and biofilm management with DEBRIX®.

𝗧𝗶𝘁𝗹𝗲: The Power of Disruptive Balance Towards Wound Healing with DEBRIX®
𝗗𝗮𝘁𝗲 & 𝘁𝗶𝗺𝗲: Wednesday, July 29, 2026 | 19:00 PM CST, Mexico City
𝗗𝘂𝗿𝗮𝘁𝗶𝗼𝗻: Approximately 60 minutes, including live Q&A
𝗦𝗽𝗲𝗮𝗸𝗲𝗿: Miguel Ángel Mellado Sanz, Advanced Practice Wound Care Nurse, Spain, a featured international speaker at the AMCICHAC Annual Congress 2025

In this session, wound care professionals will learn how DEBRIX® supports non-surgical debridement of infected wounds containing biofilm and/or necrotic tissue through a controlled 60-second application, followed by rinsing and removal of loosened debris.

The webinar will also go into detail on practical, IFU-aligned considerations for clinical decision-making process for wound bed preparation with DEBRIX® and will provide insights on integrating it into comprehensive wound care pathways.

Register now to reserve your place: https://attendee.gotowebinar.com/register/2847260583721956697

𝗢𝗿𝗴𝗮𝗻𝗶𝘇𝗲𝗿𝘀: Jointly organized by Biotechlives Skin and AMCICHAC: Asociación Mexicana para el Cuidado Integral y Cicatrización de Heridas, A.C., one of Mexico’s leading scientific organizations dedicated to advancing wound care education and best

----------------

👉 Learn more. Access all DEBRIX® publications: https://www.debx-medical.com/scientific-papers
👉 EXPERIENCE DEBRIX® FIRSTHAND. Schedule a FREE Demonstration: https://www.debx-medical.com/request-a-demonstration

30/06/2026

Biofilm is tiny architecture.

New research shows chronic wound biofilm builds ridges, folds, and channels, shaped by physical pressure as its own components push and pull against each other. The bacteria inside keep growing, bending, and shifting, and that motion sculpts the structure.

Structure drives behaviour. Those shapes reroute nutrients, trap oxygen, and shield a polymicrobial mix of S. aureus, E. coli, P. aeruginosa, Candida, and more. That is what makes these infections so persistent.

Surface-level treatments reach the top yet leave the structure intact. Here is where a 60-second topical desiccating step like DEBRICHEM® stands apart:

🔹 Broad-spectrum antimicrobial activity, producing a 54 ± 5 mm inhibition zone
🔹 Penetrates and destabilises the whole biofilm structure
🔹 Erases the protective matrix that hides infection
🔹 Clears the way for healing to resume

Full article: https://www.linkedin.com/pulse/powerful-non-antibiotic-anti-biofilm-agent-restarts-wound-buyfc/

There's no one-size-fits-all solution in wound care. It requires a combination of strategies with wound-bed preparation being the foundation of every successful approach.

29/06/2026

🎬 DEBRIX® + Microlyte® + Compression Therapy, the triple action protocol for treatment of Venous Leg Ulcers.

This video shows exactly how clinicians can combine diagnostics with this targeted therapeutic stack to kick start the healing process in Venous Leg Ulcers:

The workflow begins with data from point-of-care techniques:
➡️ pH Tracking: Lower pH downregulates bacterial multiplication.
➡️ Fluorescence Imaging: Visually detects bioburden.

Once the wound micro-environment is mapped, a three-step intervention is executed to reset the wound bed:
➡️ Precision Debridement (DEBRIX®): Safely removes the biofilm in a single 60-second application.
➡️ Microlyte®: Protects the reset wound bed environment.
➡️ Compression: Addresses the root systemic issue - venous hypertension.

Together, the workflow is: measure the wound environment, map the bacterial burden, remove the biofilm barrier with DEBRIX®, protect the reset wound bed with Microlyte®, and correct the venous driver with compression.

👇 Watch the full clinical demonstration below to see this protocol in action! Special thanks to Innovacure for making this treatment possible and recording this workflow: https://www.youtube.com/watch?v=cbgK9QTAJYw

We’re sharing a short video demonstration showing how an 8-year old...

24/06/2026

That wound smell carries a message.

Remember Volatile Organic Compounds from chemistry class? In wound care they take on fresh meaning. VOCs are metabolic by-products of bacteria, especially anaerobes, and they often sit at the root of wound malodour.

The smell speaks plainly. It can point to:
🔹 An active infection
🔹 Biofilm in residence
🔹 Tissue breakdown underway

Covering the odour leaves the cause in place. Clearing the bacterial load gets to the heart of it.

A 60-second topical desiccating step like DEBRICHEM® does exactly that. One application clears devitalised tissue, infection, and biofilm, opening the way for recovery and letting the wound bed start fresh.

Address the source, calm the scent.

22/06/2026

Oxygen helps healing, once it arrives.

Picture perfusion as a delivery truck. It carries oxygen through tiny vessels to the tissue that needs it most. When the roads stay blocked, or the truck stalls in the driveway, the oxygen waits while the wound waits longer.

That gap is tissue hypoxia, a quiet shortfall that slows healing, softens immune defence, and lets tissue break down.

In many chronic wounds, the top layer holds devitalised, infected, poorly perfused tissue. It harbours bacteria and keeps oxygen out, like a tarp thrown over a garden bed.

A 60-second topical desiccating step like DEBRICHEM® lifts that barrier in a single application, clearing devitalised tissue, infection, and biofilm. What remains is a cleaner, better-perfused wound bed, ready for oxygen to do its work and healing to move ahead.